218 related articles for article (PubMed ID: 1433178)
1. Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Sartorelli AC
J Med Chem; 1992 Oct; 35(20):3672-7. PubMed ID: 1433178
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of 4- and 5-substituted derivatives of isoquinoline-1-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Penketh P; Sartorelli AC
J Med Chem; 1995 Oct; 38(21):4234-43. PubMed ID: 7473550
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of 3- and 5-hydroxy-4-methylpyridine-2-carboxaldehyde thiosemicarbazones.
Wang Y; Liu MC; Lin TS; Sartorelli AC
J Med Chem; 1992 Oct; 35(20):3667-71. PubMed ID: 1433177
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor agents. 14. 4-Substituted 2-formylpyridine thiosemicarbazones.
Agrawal KC; Booth BA; DeNuzzo S; Sartorelli
J Med Chem; 1976 Oct; 19(10):1209-14. PubMed ID: 994151
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 12. 2-Formyl-4-aminophenylpyridine thiosemicarbazones.
Agrawal KC; Booth BA; DeNuzzo SM; Sartorelli AC
J Med Chem; 1975 Apr; 18(4):368-71. PubMed ID: 1121002
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor agents. 5. Methylated -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
Agrawal KC; Cushley RJ; Lipsky SR; Wheaton JR; Sartorelli AC
J Med Chem; 1972 Feb; 15(2):192-5. PubMed ID: 5008241
[No Abstract] [Full Text] [Related]
8. Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo.
Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
Adv Enzyme Regul; 1995; 35():55-68. PubMed ID: 7572354
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
[TBL] [Abstract][Full Text] [Related]
10. Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Kowol CR; Trondl R; Heffeter P; Arion VB; Jakupec MA; Roller A; Galanski MS; Berger W; Keppler BK
J Med Chem; 2009 Aug; 52(16):5032-43. PubMed ID: 19637923
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
Li J; Zheng LM; King I; Doyle TW; Chen SH
Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
[TBL] [Abstract][Full Text] [Related]
12. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
[TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agents. 8. Derivatives of 3- and 5-benzyloxy-2-formylpyridine thiosemicarbazone.
Lin AJ; Agrawal KC; Sartorelli AC
J Med Chem; 1972 Jun; 15(6):615-8. PubMed ID: 5030928
[No Abstract] [Full Text] [Related]
14. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
French FA; Blanz EJ
Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
[No Abstract] [Full Text] [Related]
15. 2-Acetylpyridine thiosemicarbazones. 6.2-Acetylpyridine and 2-butyrylpyridine thiosemicarbazones as antileukemic agents.
Klayman DL; Scovill JP; Mason CJ; Bartosevich JF; Bruce J; Lin AJ
Arzneimittelforschung; 1983; 33(7):909-12. PubMed ID: 6684928
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of N-heterocyclic carboxaldehyde thiosemicarbazone derivatives.
Iigo M; Hoshi A; Kuretani K; Natsume M
Gan; 1977 Apr; 68(2):221-5. PubMed ID: 892296
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Azerang P; Sardari S; Kobarfard F
Arch Pharm Res; 2021 Aug; 44(8):1-13. PubMed ID: 24062081
[TBL] [Abstract][Full Text] [Related]
18. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
[TBL] [Abstract][Full Text] [Related]
19. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
Temple C; Rose JD; Comber RN; Rener GA
J Med Chem; 1987 Oct; 30(10):1746-51. PubMed ID: 3656351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
